메뉴 건너뛰기




Volumn 31, Issue 2, 2007, Pages 441-449

Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway

Author keywords

Lysophosphatidic; Ovarian; Src; Urokinase plasminogen activator

Indexed keywords

ENZYME INHIBITOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHOLIPID; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE D; UROKINASE;

EID: 35148887739     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.2.441     Document Type: Article
Times cited : (33)

References (68)
  • 1
    • 0028903101 scopus 로고
    • Lysophosphatidic acid signalling
    • Moolenaar WH: Lysophosphatidic acid signalling. Curr Opin Cell Biol 7: 203-210, 1995.
    • (1995) Curr Opin Cell Biol , vol.7 , pp. 203-210
    • Moolenaar, W.H.1
  • 3
    • 0024428410 scopus 로고
    • Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins
    • van Corven EJ, Groenink A, Jalink K, Eichholtz T and Moolenaar WH: Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 59: 45-54, 1989.
    • (1989) Cell , vol.59 , pp. 45-54
    • Van Corven, E.J.1    Groenink, A.2    Jalink, K.3    Eichholtz, T.4    Moolenaar, W.H.5
  • 4
    • 0028038495 scopus 로고
    • Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta
    • Tokumura A, Iimori M, Nishioka Y, Kitahara M, Sakashita M and Tanaka S: Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol 267: C204-C210, 1994.
    • (1994) Am J Physiol , vol.267
    • Tokumura, A.1    Iimori, M.2    Nishioka, Y.3    Kitahara, M.4    Sakashita, M.5    Tanaka, S.6
  • 5
    • 0026795116 scopus 로고
    • Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells
    • Tigyi G and Miledi R: Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J Biol Chem 267: 21360-21367, 1992.
    • (1992) J Biol Chem , vol.267 , pp. 21360-21367
    • Tigyi, G.1    Miledi, R.2
  • 6
    • 0027583540 scopus 로고
    • Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: Similarity to thrombin action
    • Jalink K, Eichholtz T, Postma FR, van Corven EJ and Moolenaar WH: Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action. Cell Growth Differ 4: 247-255, 1993.
    • (1993) Cell Growth Differ , vol.4 , pp. 247-255
    • Jalink, K.1    Eichholtz, T.2    Postma, F.R.3    Van Corven, E.J.4    Moolenaar, W.H.5
  • 7
    • 0028004034 scopus 로고
    • Modulation of cell surface fibronectin assembly sites by lysophosphatidic acid
    • Zhang Q, Checovich WJ, Peters DM, Albrecht RM and Mosher DF: Modulation of cell surface fibronectin assembly sites by lysophosphatidic acid. J Cell Biol 127: 1447-1459, 1994.
    • (1994) J Cell Biol , vol.127 , pp. 1447-1459
    • Zhang, Q.1    Checovich, W.J.2    Peters, D.M.3    Albrecht, R.M.4    Mosher, D.F.5
  • 8
    • 0029032202 scopus 로고
    • Lysophosphatidic acid, a multifunctional phospholipid messenger
    • Moolenaar WH: Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 270: 12949-12952, 1995.
    • (1995) J Biol Chem , vol.270 , pp. 12949-12952
    • Moolenaar, W.H.1
  • 9
    • 0042887042 scopus 로고    scopus 로고
    • The emerging role of lysophosphatidic acid in cancer
    • Mills GB and Moolenaar WH: The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3: 582-591, 2003.
    • (2003) Nat Rev Cancer , vol.3 , pp. 582-591
    • Mills, G.B.1    Moolenaar, W.H.2
  • 10
    • 0034015046 scopus 로고    scopus 로고
    • Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer
    • Fang X, Gaudette D, Furui T, Mao M, Estrella V, Eder A, Pustilnik T, et al: Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann NY Acad Sci 905: 188-208, 2000.
    • (2000) Ann NY Acad Sci , vol.905 , pp. 188-208
    • Fang, X.1    Gaudette, D.2    Furui, T.3    Mao, M.4    Estrella, V.5    Eder, A.6    Pustilnik, T.7
  • 11
    • 0034083409 scopus 로고    scopus 로고
    • Constitutive and lysophosphatidic acid (LPA)-induced LPA production: Role of phospholipase D and phospholipase A2
    • Eder AM, Sasagawa T, Mao M, Aoki J and Mills GB: Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin Cancer Res 6: 2482-2491, 2000.
    • (2000) Clin Cancer Res , vol.6 , pp. 2482-2491
    • Eder, A.M.1    Sasagawa, T.2    Mao, M.3    Aoki, J.4    Mills, G.B.5
  • 12
    • 0035300534 scopus 로고    scopus 로고
    • Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells
    • Fishman DA, Liu Y, Ellerbroek SM and Stack MS: Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res 61: 3194-3199, 2001.
    • (2001) Cancer Res , vol.61 , pp. 3194-3199
    • Fishman, D.A.1    Liu, Y.2    Ellerbroek, S.M.3    Stack, M.S.4
  • 13
    • 10744225477 scopus 로고    scopus 로고
    • Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells
    • Fang X, Yu S, Bast RC, Liu S, Xu HJ, Hu SX, LaPushin R, et al: Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells. J Biol Chem 279: 9653-9661, 2004.
    • (2004) J Biol Chem , vol.279 , pp. 9653-9661
    • Fang, X.1    Yu, S.2    Bast, R.C.3    Liu, S.4    Xu, H.J.5    Hu, S.X.6    LaPushin, R.7
  • 14
    • 0027232391 scopus 로고
    • The bioactive phospholipid lysophosphatidic acid is released from activated platelets
    • Eichholtz T, Jalink K, Fahrenfort I and Moolenaar WH: The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 291: 677-680, 1993.
    • (1993) Biochem J , vol.291 , pp. 677-680
    • Eichholtz, T.1    Jalink, K.2    Fahrenfort, I.3    Moolenaar, W.H.4
  • 15
    • 0032569235 scopus 로고    scopus 로고
    • Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
    • Xu Y, Shen Z, Wiper DW, Wu M, Morton RE, Elson P, Kennedy AW, et al: Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280: 719-723, 1998.
    • (1998) JAMA , vol.280 , pp. 719-723
    • Xu, Y.1    Shen, Z.2    Wiper, D.W.3    Wu, M.4    Morton, R.E.5    Elson, P.6    Kennedy, A.W.7
  • 16
    • 0029126484 scopus 로고
    • Lysophospholipids activate ovarian and breast cancer cells
    • Xu Y, Fang XJ, Casey G and Mills GB: Lysophospholipids activate ovarian and breast cancer cells. Biochem J 309: 933-940, 1995.
    • (1995) Biochem J , vol.309 , pp. 933-940
    • Xu, Y.1    Fang, X.J.2    Casey, G.3    Mills, G.B.4
  • 18
    • 0024495699 scopus 로고
    • Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin
    • Gerrard JM and Robinson P: Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim Biophys Acta 1001: 282-285, 1989.
    • (1989) Biochim Biophys Acta , vol.1001 , pp. 282-285
    • Gerrard, J.M.1    Robinson, P.2
  • 19
    • 1542359873 scopus 로고    scopus 로고
    • Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
    • Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, et al: Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158: 227-233, 2002.
    • (2002) J Cell Biol , vol.158 , pp. 227-233
    • Umezu-Goto, M.1    Kishi, Y.2    Taira, A.3    Hama, K.4    Dohmae, N.5    Takio, K.6    Yamori, T.7    Mills, G.B.8
  • 20
    • 0037374562 scopus 로고    scopus 로고
    • The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: Validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer
    • Tanyi JL, Morris AJ, Wolf JK, Fang X, Hasegawa Y, Lapushin R, Auersperg N, et al: The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. Cancer Res 63: 1073-1082, 2003.
    • (2003) Cancer Res , vol.63 , pp. 1073-1082
    • Tanyi, J.L.1    Morris, A.J.2    Wolf, J.K.3    Fang, X.4    Hasegawa, Y.5    Lapushin, R.6    Auersperg, N.7
  • 21
    • 0034700050 scopus 로고    scopus 로고
    • Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior
    • Contos JJ, Fukushima N, Weiner JA, Kaushal D and Chun J: Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA 97: 13384-13389, 2000.
    • (2000) Proc Natl Acad Sci USA , vol.97 , pp. 13384-13389
    • Contos, J.J.1    Fukushima, N.2    Weiner, J.A.3    Kaushal, D.4    Chun, J.5
  • 22
    • 0036786445 scopus 로고    scopus 로고
    • Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: Signaling deficits without obvious phenotypic abnormality attributable to lpa(2)
    • Contos JJ, Ishii I, Fukushima N, Kingsbury MA, Ye X, Kawamura S, Brown JH and Chun J: Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol Cell Biol 22: 6921-6929, 2002.
    • (2002) Mol Cell Biol , vol.22 , pp. 6921-6929
    • Contos, J.J.1    Ishii, I.2    Fukushima, N.3    Kingsbury, M.A.4    Ye, X.5    Kawamura, S.6    Brown, J.H.7    Chun, J.8
  • 23
    • 0942301169 scopus 로고    scopus 로고
    • Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2)
    • Huang MC, Lee HY, Yeh CC, Kong Y, Zaloudek CJ and Goetzl EJ: Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2). Oncogene 23: 122-129, 2004.
    • (2004) Oncogene , vol.23 , pp. 122-129
    • Huang, M.C.1    Lee, H.Y.2    Yeh, C.C.3    Kong, Y.4    Zaloudek, C.J.5    Goetzl, E.J.6
  • 24
    • 0031788478 scopus 로고    scopus 로고
    • Activation of c-Jun N-terminal kinase (JNK) by lysophosphatidic acid in Swiss 3T3 fibroblasts
    • Sasaki T, Maehama T, Yamamoto T, Takasuga S, Hoshino S, Nishina H, Hazeki O, et al: Activation of c-Jun N-terminal kinase (JNK) by lysophosphatidic acid in Swiss 3T3 fibroblasts. J Biochem 124: 934-939, 1998.
    • (1998) J Biochem , vol.124 , pp. 934-939
    • Sasaki, T.1    Maehama, T.2    Yamamoto, T.3    Takasuga, S.4    Hoshino, S.5    Nishina, H.6    Hazeki, O.7
  • 25
    • 0030044360 scopus 로고    scopus 로고
    • Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
    • Daub H, Weiss FU, Wallasch C and Ullrich A: Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379: 557-560, 1996.
    • (1996) Nature , vol.379 , pp. 557-560
    • Daub, H.1    Weiss, F.U.2    Wallasch, C.3    Ullrich, A.4
  • 26
    • 0028977847 scopus 로고
    • Receptor-tyrosine-kinase- And G beta gamma-mediated MAP kinase activation by a common signalling pathway
    • van Biesen T, Hawes BE, Luttrell DK, Krueger KM, Touhara K, Porfiri E, Sakaue M, et al: Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. Nature 376: 781-784, 1995.
    • (1995) Nature , vol.376 , pp. 781-784
    • Van Biesen, T.1    Hawes, B.E.2    Luttrell, D.K.3    Krueger, K.M.4    Touhara, K.5    Porfiri, E.6    Sakaue, M.7
  • 27
    • 0029778177 scopus 로고    scopus 로고
    • Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases
    • Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ and Lefkowitz RJ: Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 271: 19443-19450, 1996.
    • (1996) J Biol Chem , vol.271 , pp. 19443-19450
    • Luttrell, L.M.1    Hawes, B.E.2    Van Biesen, T.3    Luttrell, D.K.4    Lansing, T.J.5    Lefkowitz, R.J.6
  • 29
    • 0028908979 scopus 로고
    • Lysophosphatidic acid induction of transforming growth factors alpha and beta: Modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin
    • Piazza GA, Ritter JL and Baracka CA: Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp Cell Res 216: 51-64, 1995.
    • (1995) Exp Cell Res , vol.216 , pp. 51-64
    • Piazza, G.A.1    Ritter, J.L.2    Baracka, C.A.3
  • 32
    • 0029079407 scopus 로고
    • The urokinase/urokinase-receptor system and cancer invasion
    • Conese M and Blasi F: The urokinase/urokinase-receptor system and cancer invasion. Baillieres Clin Haematol 8: 365-389, 1995.
    • (1995) Baillieres Clin Haematol , vol.8 , pp. 365-389
    • Conese, M.1    Blasi, F.2
  • 33
    • 0030002073 scopus 로고    scopus 로고
    • Proteases as prognostic markers in cancer
    • Duffy MJ: Proteases as prognostic markers in cancer. Clin Cancer Res 2: 613-618, 1996.
    • (1996) Clin Cancer Res , vol.2 , pp. 613-618
    • Duffy, M.J.1
  • 34
    • 0026517693 scopus 로고
    • Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin
    • van Corven EJ, van Rijswijk A, Jalink K, van der Bend RL, van Blitterswijk WJ and Moolenaar WH: Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin. Biochem J 281: 163-169, 1992.
    • (1992) Biochem J , vol.281 , pp. 163-169
    • Van Corven, E.J.1    Van Rijswijk, A.2    Jalink, K.3    Van Der Bend, R.L.4    Van Blitterswijk, W.J.5    Moolenaar, W.H.6
  • 35
    • 0033555721 scopus 로고    scopus 로고
    • PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor
    • Takeda H, Matozaki T, Takada T, Noguchi T, Yamao T, Tsuda M, Ochi F, et al: PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor. EMBO J 18: 386-395, 1999.
    • (1999) EMBO J , vol.18 , pp. 386-395
    • Takeda, H.1    Matozaki, T.2    Takada, T.3    Noguchi, T.4    Yamao, T.5    Tsuda, M.6    Ochi, F.7
  • 37
    • 0030959278 scopus 로고    scopus 로고
    • Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity
    • Fang X, Gibson S, Flowers M, Furui T, Bast RC Jr and Mills GB: Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity. J Biol Chem 272: 13683-13689, 1997.
    • (1997) J Biol Chem , vol.272 , pp. 13683-13689
    • Fang, X.1    Gibson, S.2    Flowers, M.3    Furui, T.4    Bast Jr., R.C.5    Mills, G.B.6
  • 38
    • 0030737427 scopus 로고    scopus 로고
    • G-Protein-coupled receptors and Fcgamma-receptors mediate activation of Akt/protein kinase B in human phagocytes
    • Tilton B, Andjelkovic M, Didichenko SA, Hemmings BA and Thelen M: G-Protein-coupled receptors and Fcgamma-receptors mediate activation of Akt/protein kinase B in human phagocytes. J Biol Chem 272: 28096-28101, 1997.
    • (1997) J Biol Chem , vol.272 , pp. 28096-28101
    • Tilton, B.1    Andjelkovic, M.2    Didichenko, S.A.3    Hemmings, B.A.4    Thelen, M.5
  • 39
    • 0029043582 scopus 로고
    • How MAP kinases are regulated
    • Cobb MH and Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
    • (1995) J Biol Chem , vol.270 , pp. 14843-14846
    • Cobb, M.H.1    Goldsmith, E.J.2
  • 40
    • 0030970723 scopus 로고    scopus 로고
    • Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src
    • Staley CA, Parikh NU and Gallick GE: Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src. Cell Growth Differ 8: 269-274, 1997.
    • (1997) Cell Growth Differ , vol.8 , pp. 269-274
    • Staley, C.A.1    Parikh, N.U.2    Gallick, G.E.3
  • 41
    • 0032812095 scopus 로고    scopus 로고
    • Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model
    • Wiener JR, Nakano K, Kruzelock RP, Bucana CD, Bast RC Jr and Gallick GE: Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model. Clin Cancer Res 5: 2164-2170, 1999. (Pubitemid 29399273)
    • (1999) Clinical Cancer Research , vol.5 , Issue.8 , pp. 2164-2170
    • Wiener, J.R.1    Nakano, K.2    Kruzelock, R.P.3    Bucana, C.D.4    Bast Jr., R.C.5    Gallick, G.E.6
  • 42
    • 0034726004 scopus 로고    scopus 로고
    • Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors
    • Bandoh K, Aoki J, Taira A, Tsujimoto M, Arai H and Inoue K: Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett 478: 159-165, 2000.
    • (2000) FEBS Lett , vol.478 , pp. 159-165
    • Bandoh, K.1    Aoki, J.2    Taira, A.3    Tsujimoto, M.4    Arai, H.5    Inoue, K.6
  • 43
    • 0037809241 scopus 로고    scopus 로고
    • Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor
    • Hasegawa Y, Erickson JR, Goddard GJ, Yu S, Liu S, Cheng KW, Eder A, et al: Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor. J Biol Chem 278: 11962-11969, 2003.
    • (2003) J Biol Chem , vol.278 , pp. 11962-11969
    • Hasegawa, Y.1    Erickson, J.R.2    Goddard, G.J.3    Yu, S.4    Liu, S.5    Cheng, K.W.6    Eder, A.7
  • 45
    • 0038364216 scopus 로고    scopus 로고
    • The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy
    • DOI 10.1023/A:1023099415940
    • Sidenius N and Blasi F: The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 22: 205-222, 2003. (Pubitemid 36561058)
    • (2003) Cancer and Metastasis Reviews , vol.22 , Issue.2-3 , pp. 205-222
    • Sidenius, N.1    Blasi, F.2
  • 47
    • 0742307276 scopus 로고    scopus 로고
    • Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression
    • Murthi P, Barker G, Nowell CJ, Rice GE, Baker MS, Kalionis B and Quinn MA: Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression. Gynecol Oncol 92: 80-88, 2004.
    • (2004) Gynecol Oncol , vol.92 , pp. 80-88
    • Murthi, P.1    Barker, G.2    Nowell, C.J.3    Rice, G.E.4    Baker, M.S.5    Kalionis, B.6    Quinn, M.A.7
  • 48
    • 0034892043 scopus 로고    scopus 로고
    • Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer
    • Schmalfeldt B, Prechtel D, Harting K, Spathe K, Rutke S, Konik E, Fridman R, et al: Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 7: 2396-2404, 2001.
    • (2001) Clin Cancer Res , vol.7 , pp. 2396-2404
    • Schmalfeldt, B.1    Prechtel, D.2    Harting, K.3    Spathe, K.4    Rutke, S.5    Konik, E.6    Fridman, R.7
  • 49
    • 0035874046 scopus 로고    scopus 로고
    • Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)
    • DOI 10.1002/ijc.1215
    • Borgfeldt C, Hansson SR, Gustavsson B, Masback A and Casslen B: Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1). Int J Cancer 92: 497-502, 2001. (Pubitemid 32319422)
    • (2001) International Journal of Cancer , vol.92 , Issue.4 , pp. 497-502
    • Borgfeldt, C.1    Hansson, S.R.2    Gustavsson, B.3    Masback, A.4    Casslen, B.5
  • 50
    • 0028656476 scopus 로고
    • Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy
    • Kuhn W, Pache L, Schmalfeldt B, Dettmar P, Schmitt M, Janicke F and Graeff H: Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy. Gynecol Oncol 55: 401-409, 1994.
    • (1994) Gynecol Oncol , vol.55 , pp. 401-409
    • Kuhn, W.1    Pache, L.2    Schmalfeldt, B.3    Dettmar, P.4    Schmitt, M.5    Janicke, F.6    Graeff, H.7
  • 51
    • 0034901514 scopus 로고    scopus 로고
    • Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer
    • Konecny G, Untch M, Pihan A, Kimmig R, Gropp M, Stieber P, Hepp H, et al: Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer. Clin Cancer Res 7: 1743-1749, 2001.
    • (2001) Clin Cancer Res , vol.7 , pp. 1743-1749
    • Konecny, G.1    Untch, M.2    Pihan, A.3    Kimmig, R.4    Gropp, M.5    Stieber, P.6    Hepp, H.7
  • 52
    • 0032582802 scopus 로고    scopus 로고
    • Urokinase induces proliferation of human ovarian cancer cells: Characterization of structural elements required for growth factor function
    • Fischer K, Lutz V, Wilhelm O, Schmitt M, Graeff H, Heiss P, Nishiguchi T, et al: Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function. FEBS Lett 438: 101-105, 1998.
    • (1998) FEBS Lett , vol.438 , pp. 101-105
    • Fischer, K.1    Lutz, V.2    Wilhelm, O.3    Schmitt, M.4    Graeff, H.5    Heiss, P.6    Nishiguchi, T.7
  • 53
    • 0033179049 scopus 로고    scopus 로고
    • Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type- plasminogen-activator N-terminal fragment
    • DOI 10.1042/0264-6021:3410765
    • Fishman DA, Kearns A, Larsh S, Enghild JJ and Stack MS: Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment. Biochem J 341: 765-769, 1999. (Pubitemid 29389209)
    • (1999) Biochemical Journal , vol.341 , Issue.3 , pp. 765-769
    • Fishman, D.A.1    Kearns, A.2    Larsh, S.3    Enghild, J.J.4    Stack, M.S.5
  • 54
    • 0035911966 scopus 로고    scopus 로고
    • Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin
    • DOI 10.1083/jcb.152.6.1145
    • Kjoller L and Hall A: Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J Cell Biol 152: 1145-1157, 2001. (Pubitemid 34280173)
    • (2001) Journal of Cell Biology , vol.152 , Issue.6 , pp. 1145-1157
    • Kjoller, L.1    Hall, A.2
  • 55
    • 0029007784 scopus 로고
    • Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice
    • Wilhelm O, Schmitt M, Hohl S, Senekowitsch R and Graeff H: Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice. Clin Exp Metastasis 13: 296-302, 1995.
    • (1995) Clin Exp Metastasis , vol.13 , pp. 296-302
    • Wilhelm, O.1    Schmitt, M.2    Hohl, S.3    Senekowitsch, R.4    Graeff, H.5
  • 56
    • 0037174147 scopus 로고    scopus 로고
    • High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: Effects on tumor growth and spread
    • Sato S, Kopitz C, Schmalix WA, Muehlenweg B, Kessler H, Schmitt M, Kruger A, et al: High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread. FEBS Lett 528: 212-216, 2002.
    • (2002) FEBS Lett , vol.528 , pp. 212-216
    • Sato, S.1    Kopitz, C.2    Schmalix, W.A.3    Muehlenweg, B.4    Kessler, H.5    Schmitt, M.6    Kruger, A.7
  • 57
    • 0037431429 scopus 로고    scopus 로고
    • Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin
    • Suzuki M, Kobayashi H, Tanaka Y, Hirashima Y, Kanayama N, Takei Y, Saga Y, et al: Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin. Int J Cancer 104: 289-302, 2003.
    • (2003) Int J Cancer , vol.104 , pp. 289-302
    • Suzuki, M.1    Kobayashi, H.2    Tanaka, Y.3    Hirashima, Y.4    Kanayama, N.5    Takei, Y.6    Saga, Y.7
  • 58
    • 0031960208 scopus 로고    scopus 로고
    • Thrombin activates two stress-activated protein kinases, c-Jun N- Terminal kinase and p38, in HepG2 cells
    • DOI 10.1002/hep.510270524
    • Mitsui H, Maruyama T, Kimura S and Takuwa Y: Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells. Hepatology 27: 1362-1367, 1998. (Pubitemid 28227865)
    • (1998) Hepatology , vol.27 , Issue.5 , pp. 1362-1367
    • Mitsui, H.1    Maruyama, T.2    Kimura, S.3    Takuwa, Y.4
  • 59
    • 0027170176 scopus 로고
    • RapV12 antagonizes ras-dependent activation of ERK1 and ERK2 by LPA and EGF in rat-1 fibroblasts
    • Cook SJ, Rubinfeld B, Albert I and McCormick F: RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J 12: 3475-3485, 1993. (Pubitemid 23256435)
    • (1993) EMBO Journal , vol.12 , Issue.9 , pp. 3475-3485
    • Cook, S.J.1    Rubinfeld, B.2    Albert, I.3    McCormick, F.4
  • 60
    • 0031037296 scopus 로고    scopus 로고
    • Linkage of g protein-coupled receptors to the MAPK signaling pathway through Pl 3-kinase gamma
    • DOI 10.1126/science.275.5298.394
    • Lopez-Ilasaca M, Crespo P, Pellici PG, Gutkind JS and Wetzker R: Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 275: 394-397, 1997. (Pubitemid 27051618)
    • (1997) Science , vol.275 , Issue.5298 , pp. 394-397
    • Lopez-Ilasaca, M.1    Crespo, P.2    Pellici, P.G.3    Gutkind, J.S.4    Wetzker, R.5
  • 61
    • 0031725052 scopus 로고    scopus 로고
    • A function for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in fibroblasts during mitogenesis: Requirement for insulin- And lysophosphatidic acid-mediated signal transduction
    • Roche S, Downward J, Raynal P and Courtneidge SA: A function for phosphatidylinositol 3-kinase beta (p85alphap110beta) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol Cell Biol 18: 7119-7129, 1998. (Pubitemid 28533031)
    • (1998) Molecular and Cellular Biology , vol.18 , Issue.12 , pp. 7119-7129
    • Roche, S.1    Downward, J.2    Raynal, P.3    Courtneidge, S.A.4
  • 62
    • 9644262476 scopus 로고    scopus 로고
    • P38 mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression
    • DOI 10.1074/jbc.M409221200
    • Yu J, Bian D, Mahanivong C, Cheng RK, Zhou W and Huang S: p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression. J Biol Chem 279: 50446-50454, 2004. (Pubitemid 39577863)
    • (2004) Journal of Biological Chemistry , vol.279 , Issue.48 , pp. 50446-50454
    • Yu, J.1    Bian, D.2    Mahanivong, C.3    Cheng, R.K.4    Zhou, W.5    Huang, S.6
  • 63
    • 0035930504 scopus 로고    scopus 로고
    • v Integrin, p38 Mitogen-activated Protein Kinase, and Urokinase Plasminogen Activator Are Functionally Linked in Invasive Breast Cancer Cells
    • Chen J, Baskerville C, Han Q, Pan ZK and Huang S: Alpha(v) integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells. J Biol Chem 276: 47901-47905, 2001. (Pubitemid 37370687)
    • (2001) Journal of Biological Chemistry , vol.276 , Issue.51 , pp. 47901-47905
    • Chen, J.1    Baskerville, C.2    Han, Q.3    Pan, Z.K.4    Huang, S.5
  • 64
    • 15444368022 scopus 로고    scopus 로고
    • Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells
    • DOI 10.1074/jbc.M412152200
    • Li H, Ye X, Mahanivong C, Bian D, Chun J and Huang S: Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. J Biol Chem 280: 10564-10571, 2005. (Pubitemid 40395917)
    • (2005) Journal of Biological Chemistry , vol.280 , Issue.11 , pp. 10564-10571
    • Li, H.1    Ye, X.2    Mahanivong, C.3    Bian, D.4    Chun, J.5    Huang, S.6
  • 65
    • 0029907265 scopus 로고    scopus 로고
    • A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation
    • DOI 10.1038/383547a0
    • Dikic I, Tokiwa G, Lev S, Courtneidge SA and Schlessinger J: A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383: 547-550, 1996. (Pubitemid 26346184)
    • (1996) Nature , vol.383 , Issue.6600 , pp. 547-550
    • Dikic, I.1    Tokiwa, G.2    Lev, S.3    Courtneidge, S.A.4    Schlessinger, J.5
  • 66
    • 1542305671 scopus 로고    scopus 로고
    • Transforming Growth Factor-beta1-dependent Urokinase Up-regulation and Promotion of Invasion Are Involved in Src-MAPK-dependent Signaling in Human Ovarian Cancer Cells
    • DOI 10.1074/jbc.M309131200
    • Tanaka Y, Kobayashi H, Suzuki M, Kanayama N and Terao T: Transforming growth factor-beta1-dependent urokinase upregulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J Biol Chem 279: 8567-8576, 2004. (Pubitemid 38295910)
    • (2004) Journal of Biological Chemistry , vol.279 , Issue.10 , pp. 8567-8576
    • Tanaka, Y.1    Kobayashi, H.2    Suzuki, M.3    Kanayama, N.4    Terao, T.5
  • 67
    • 0035866381 scopus 로고    scopus 로고
    • Upregulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase
    • Dunn SE, Torres JV, Oh JS, Cykert DM and Barrett JC: Upregulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase. Cancer Res 61: 1367-1374, 2001.
    • (2001) Cancer Res , vol.61 , pp. 1367-1374
    • Dunn, S.E.1    Torres, J.V.2    Oh, J.S.3    Cykert, D.M.4    Barrett, J.C.5
  • 68
    • 0032697491 scopus 로고    scopus 로고
    • Regulation by p38 mitogen-activated protein kinase of adenylate- And uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion
    • Montero L and Nagamine Y: Regulation by p38 mitogenactivated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion. Cancer Res 59: 5286-5293, 1999. (Pubitemid 29503996)
    • (1999) Cancer Research , vol.59 , Issue.20 , pp. 5286-5293
    • Montero, L.1    Nagamine, Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.